SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-018848
Filing Date
2023-09-13
Accepted
2023-09-13 20:45:11
Documents
2
Period of Report
2023-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3053
2 EX-24 DOCUMENT attachment1.htm EX-24 3899
  Complete submission text file 0000899243-23-018848.txt   8432
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Issuer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address
Savitz Ryan (Reporting) CIK: 0001992324 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38541 | Film No.: 231253875